Cancer Treatment

Singapore and Nanjing, China, November 4, 2026 IASO Bio has officially launched FUCASO (equecabtagene autoleucel) in Singapore, marking an...

Aachen, Germany, September 21, 2026 Grünenthal has announced an agreement with Bayer AG to acquire Stivarga® (regorafenib), an established...

Indianapolis, Indiana, September 18, 2026 Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA)...

New York, New York, U.S., September 15, 2026 Olatec Therapeutics, Inc., a clinical-stage biotechnology company developing therapies for inflammatory...

Tokyo, Japan, September 17, 2026 Astellas Pharma Inc. has announced that the European Medicines Agency’s Committee for Medicinal Products...

Hong Kong, September 17, 2026 Akeso, Inc. has announced that its investigational AK158D1, a next-generation EGFR/TROP2 bispecific antibody-drug conjugate...

Basel, Switzerland, September 17, 2026 Roche has announced positive results from the Phase III CELESTIMO study, showing that a...

RESEARCH TRIANGLE PARK, N.C. — September 17, 2026 Fennec Pharmaceuticals announced the oral presentation of detailed results from the...

WOBURN, Mass. — September 14, 2026 Biofrontera Inc. announced that the U.S. Food and Drug Administration (FDA) has approved...

Hong Kong, China, September 11, 2026 Ocumension Therapeutics has announced that the National Medical Products Administration (NMPA) of China...